polifeprosan 20 with carmustine implant
Sponsors
Duke University, Barrett Cancer Center, New Approaches to Brain Tumor Therapy Consortium, National Cancer Institute (NCI), Pediatric Brain Tumor Consortium
Conditions
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Phase 1
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
TerminatedNCT00045721
Start: 2003-03-31End: 2004-07-31Updated: 2009-10-16
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
CompletedNCT00003463
Start: 1998-07-31End: 2002-07-31Updated: 2013-02-18
O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
CompletedNCT00004892
Start: 2000-04-30Updated: 2009-02-09
Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
CompletedNCT00003876
Start: 1999-04-30End: 2004-05-31Updated: 2013-06-26
Phase 2
Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
CompletedNCT00003467
Start: 1998-01-31End: 2004-02-29Target: 68Updated: 2013-06-20
Carmustine Implants in Treating Patients With Brain Metastases
CompletedNCT00003878
Start: 2002-04-30End: 2003-04-30Updated: 2013-06-21
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
WithdrawnNCT00814593
Start: 2008-11-30End: 2011-09-30Updated: 2019-05-10